The farnesoid X receptor induces very low density lipoprotein receptor gene expression

被引:86
作者
Sirvent, A
Claudel, T
Martin, G
Brozek, J
Kosykh, V
Darteil, RL
Hum, DW
Fruchart, JC
Staels, B
机构
[1] Inst Pasteur, INSERM, UR 545, Dept Atherosclerose, F-59019 Lille, France
[2] Univ Lille 2, Fac Pharm, F-59019 Lille, France
[3] GENFIT, Loos, France
[4] IT OMICS, Loos, France
[5] Acad Med Sci, Cardiol Res Ctr, Moscow, Russia
来源
FEBS LETTERS | 2004年 / 566卷 / 1-3期
关键词
farnesoid X receptor; microarray analysis; VLDL receptor; small interfering RNA;
D O I
10.1016/j.febslet.2004.04.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The farnesoid X receptor (FXR) is a nuclear receptor activated by bile acids (BAs). In response to ligand-binding, FXR regulates many genes involved in BA, lipid, and lipoprotein metabolism. To identify new FXR target genes, microarray technology was used to profile total RNA extracted from HepG2 cells treated with the natural FXR agonist chenodeoxycholic acid (CDCA). Interestingly, a significant increase of transcript level of the very low density lipoprotein receptor (VLDLR) was observed. Our data, resulting from selective FXR activation, FXR RNA silencing and FXR-deficient mice, clearly demonstrate that BAs up-regulate VLDLR transcript levels via a FXR-dependent mechanism in vitro in human and in vivo in mouse liver cells. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 37 条
  • [1] FXR induces the UGT2B4 enzyme in hepatocytes: A potential mechanism of negative feedback control of FXR activity
    Barbier, O
    Torra, IP
    Sirvent, A
    Claudel, T
    Blanquart, C
    Duran-Sandoval, D
    Kuipers, F
    Kosykh, V
    Fruchart, JC
    Staels, B
    [J]. GASTROENTEROLOGY, 2003, 124 (07) : 1926 - 1940
  • [2] EFFECTS OF INTERRUPTION OF THE ENTEROHEPATIC CIRCULATION OF BILE-ACIDS ON THE TRANSPORT OF VERY LOW-DENSITY LIPOPROTEIN TRIGLYCERIDES
    BEIL, U
    CROUSE, JR
    EINARSSON, K
    GRUNDY, SM
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05): : 438 - 444
  • [3] CHIPPES IJ, 1997, CELL BIOL TOXICOL, V13, P375
  • [4] Claudel T, 2002, J CLIN INVEST, V109, P961
  • [5] Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
    Claudel, T
    Inoue, Y
    Barbier, O
    Duran-Sandoval, D
    Kosykh, V
    Fruchart, J
    Fruchart, JC
    Gonzalez, FJ
    Staels, B
    [J]. GASTROENTEROLOGY, 2003, 125 (02) : 544 - 555
  • [6] Davis RA, 2002, J LIPID RES, V43, P533
  • [7] The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp
    Denson, LA
    Sturm, E
    Echevarria, W
    Zimmerman, TL
    Makishima, M
    Mangelsdorf, DJ
    Karpen, SJ
    [J]. GASTROENTEROLOGY, 2001, 121 (01) : 140 - 147
  • [8] NORMAL PLASMA-LIPOPROTEINS AND FERTILITY IN GENE-TARGETED MICE HOMOZYGOUS FOR A DISRUPTION IN THE GENE ENCODING VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR
    FRYKMAN, PK
    BROWN, MS
    YAMAMOTO, T
    GOLDSTEIN, JL
    HERZ, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8453 - 8457
  • [9] A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
    Goodwin, B
    Jones, SA
    Price, RR
    Watson, MA
    McKee, DD
    Moore, LB
    Galardi, C
    Wilson, JG
    Lewis, MC
    Roth, ME
    Maloney, PR
    Willson, TM
    Kliewer, SA
    [J]. MOLECULAR CELL, 2000, 6 (03) : 517 - 526
  • [10] Protection from obesity in mice lacking the VLDL receptor
    Goudriaan, JR
    Tacken, PJ
    Dahlmans, VEH
    Gijbels, MJJ
    van Dijk, KW
    Havekes, LM
    Jong, MC
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) : 1488 - 1493